Abstract: The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, poly-glutamic acid, and a bioactive agent for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability for oral drug delivery.
Type:
Grant
Filed:
March 4, 2011
Date of Patent:
October 18, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses a pharmaceutical composition of the nanoparticles composed of chitosan, a negatively charged substrate, a transition metal ion, and at least one bioactive agent for drug delivery. The nanoparticles are characterized with a positive surface charge configured for promoting enhanced permeability for bioactive agent delivery.
Type:
Grant
Filed:
January 15, 2011
Date of Patent:
August 30, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one anti-hemophilic factor or bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug delivery.
Type:
Grant
Filed:
February 15, 2011
Date of Patent:
August 16, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, poly-glutamic acid, and a bioactive agent for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability for oral drug delivery.
Type:
Grant
Filed:
March 10, 2011
Date of Patent:
August 16, 2011
Assignees:
GP Medical, Inc., National Tsing Huu University
Abstract: The invention discloses nanoparticles composed of chitosan, poly-glutamic acid, and at least one bioactive agent characterized with a positive surface charge. The bioactive agent is hydrophobic or lipophilic in nature and is associated with micelles before being encapsulated in nanoparticles.
Type:
Grant
Filed:
January 26, 2011
Date of Patent:
August 9, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, poly-glutamic acid, and a pegylated bioactive agent for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability for oral drug delivery.
Type:
Grant
Filed:
February 17, 2011
Date of Patent:
August 9, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one antibiotics or equivalent bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug delivery.
Type:
Grant
Filed:
January 27, 2011
Date of Patent:
August 2, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses the bioactive nanoparticles composed of chitosan, poly-glutamic acid, and at least one bioactive agent characterized with a positive surface charge and enhanced permeability in oral drug delivery.
Type:
Grant
Filed:
August 5, 2009
Date of Patent:
April 5, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one protein drug or bioactive agent characterized with a positive surface charge and their enhanced permeability for paracellular protein drug and bioactive agent delivery.
Type:
Grant
Filed:
March 6, 2009
Date of Patent:
April 5, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, poly-glutamic acid, and a bioactive agent for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability for oral drug delivery.
Type:
Grant
Filed:
April 21, 2010
Date of Patent:
March 22, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses a pharmaceutical composition for treating a subject comprising two or more bioactive nanoparticles, thus treating the subject by co-administering the bioactive nanoparticles to the subject, wherein a first and a second bioactive nanoparticles comprise a shell portion that is dominated by positively charged chitosan, a core portion that contains negatively charged substrate, and at least a first bioactive agent in the first nanoparticle and a second bioactive agent in the second nanoparticle.
Type:
Grant
Filed:
June 1, 2009
Date of Patent:
March 8, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses the biodegradable nanoparticle for use in nanoparticle projectile bombardment as a carrier for administering proteins, peptides or siRNAs transdermally to an animal subject. The nanoparticles are composed of positively charged chitosan substrate, negatively charged core substrate complexed with chitosan, and encapsulated bioactive agents.
Type:
Grant
Filed:
October 16, 2007
Date of Patent:
March 8, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Inventors:
Hsing-Wen Sung, Mei-Chin Chen, Po-Wei Lee, Hosheng Tu
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one anti-hemophilic factor or bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug delivery.
Type:
Grant
Filed:
February 20, 2009
Date of Patent:
March 1, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one bioactive agent of HMG-CoA reductase inhibitors or erythropoietin. The nanoparticles are characterized with a positive surface charge and their enhanced permeability for paracellular drug delivery.
Type:
Grant
Filed:
May 26, 2006
Date of Patent:
February 1, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Inventors:
Hsing-Wen Sung, Yu-Hsin Lin, Mei-Chin Chen, Hosheng Tu
Abstract: The invention discloses nanoparticles composed of chitosan, poly-glutamic acid, and at least one bioactive agent characterized with a positive surface charge. The bioactive agent is hydrophobic or lipophilic in nature and is associated with micelles before being encapsulated in nanoparticles.
Type:
Grant
Filed:
May 24, 2010
Date of Patent:
February 1, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one antibiotics or equivalent bioactive agent characterized with a positive surface charge and their enhanced permeability in oral drug delivery.
Type:
Grant
Filed:
June 1, 2009
Date of Patent:
February 1, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one DNA/RNA or bioactive agent characterized with a positive surface charge and their enhanced permeability for gene delivery and bioactive agent delivery.
Type:
Grant
Filed:
May 23, 2009
Date of Patent:
February 1, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Inventors:
Hsing-Wen Sung, Shu-Fen Peng, Hosheng Tu
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one protein drug or bioactive agent characterized with a positive surface charge and their enhanced permeability for paracellular protein drug and bioactive agent delivery.
Type:
Grant
Filed:
January 26, 2009
Date of Patent:
January 18, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid as drug carriers, and encapsulating at least one bioactive agent. The nanoparticles are characterized with a positive surface charge configured for promoting enhanced permeability for bioactive agent delivery.
Type:
Grant
Filed:
February 2, 2009
Date of Patent:
January 18, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Abstract: The invention discloses the nanoparticles composed of chitosan, poly-glutamic acid, and at least one protein drug or bioactive agent characterized with a positive surface charge and their enhanced permeability for paracellular protein drug and bioactive agent delivery.
Type:
Grant
Filed:
June 24, 2009
Date of Patent:
January 18, 2011
Assignees:
GP Medical, Inc., National Tsing Hua University
Inventors:
Hsing-Wen Sung, Hsiang-Fa Liang, Hosheng Tu